[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Crisis |
|
|
Clinical Trial: BMS-354825 in Subjects with Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to see what effect an investigational drug (BMS-354825) has on subjects who are currently in the myeloid blast phase of chronic myeloid leukemia (CML) and who are either resistant to or intolerant of imatinib mesylate. Another purpose of the study is to see what side effects this drug may have on subjects.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Chronic Myeloid Leukemia Blast Crisis | Drug: BMS-354825 | Phase II |
MedlinePlus related topics: Cancer; Cancer Alternative Therapy; Leukemia, Adult Acute; Leukemia, Adult Chronic; Leukemia, Childhood
Study Type: Interventional
Study Design: Treatment
Official Title: A Phase II Study of BMS-354825 in Subjects with Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Subjects with myeloid blast phase chronic myeloid leukemia
- Subjects who are either resistant or intolerant of imatinib mesylate
Exclusion Criteria:
- Subjects who are eligible and willing to undergo transplantation
- Serious uncontrolled medical disorder or active infection
- Uncontrolled or significant heart problems, such as congestive heart failure, recent heart attack, etc.
- Subjects receiving medications that may affect heart rhythm
- Other malignancy/cancer other than CML
- History of significant bleeding disorder unrelated to CML
- Pregnant or breastfeeding women (subjects must avoid becoming pregnant)
- Subjects received imatinib within 7 days, interferon or cytarabine within 14 days, a targeted anticancer medication within 14 days, an antineoplastic agent (other than hydroxyurea or anagrelide) within 28 days, or any other investigation medication in 28 days
- Subject is receiving medications that affect platelet function or an anticoagulant
Location and Contact Information
BMS Call Center Outside the US and Canada 1-215-347-4079
Alabama
Local Institution, Birmingham, Alabama, United States; Recruiting
Arizona
Local Institution, Phoenix, Arizona, United States; Not yet recruiting
California
Local Institution, Los Angeles, California, United States; Recruiting
Local Institution, Stanford, California, United States; Recruiting
Local Institution, La Jolla, California, United States; Not yet recruiting
Local Institution, Vallejo, California, United States; Not yet recruiting
Local Institution, Anaheim, California, United States; Not yet recruiting
Colorado
Local Institution, Denver, Colorado, United States; Recruiting
Local Institution, Colorado Springs, Colorado, United States; Not yet recruiting
Connecticut
Local Institution, Hartford, Connecticut, United States; Not yet recruiting
Local Institution, West Haven, Connecticut, United States; Not yet recruiting
District of Columbia
Local Institution, Washington, District of Columbia, United States; Not yet recruiting
Florida
Local Institution, Tampa, Florida, United States; Not yet recruiting
Local Institution, Jacksonville, Florida, United States; Not yet recruiting
Georgia
Local Institution, Atlanta, Georgia, United States; Recruiting
Local Institution, Tucker, Georgia, United States; Not yet recruiting
Illinois
Local Institution, Chicago, Illinois, United States; Recruiting
Local Institution, Chicago, Illinois, United States; Not yet recruiting
Indiana
Local Institution, Indianapolis, Indiana, United States; Not yet recruiting
Iowa
Local Institution, Iowa City, Iowa, United States; Not yet recruiting
Kansas
Local Institution, Kansas City, Kansas, United States; Not yet recruiting
Kentucky
Local Institution, Louisville, Kentucky, United States; Recruiting
Local Institution, Lexington, Kentucky, United States; Not yet recruiting
Louisiana
Local Institution, Shreveport, Louisiana, United States; Not yet recruiting
Maryland
Local Institution, Baltimore, Maryland, United States; Not yet recruiting
Massachusetts
Local Institution, Boston, Massachusetts, United States; Not yet recruiting
Michigan
Local Institution, Detroit, Michigan, United States; Recruiting
Minnesota
Local Institution, Rochester, Minnesota, United States; Not yet recruiting
Missouri
Local Institution, St. Louis, Missouri, United States; Not yet recruiting
Nebraska
Local Institution, Omaha, Nebraska, United States; Not yet recruiting
Local Institution, Omaha, Nebraska, United States; Not yet recruiting
New Jersey
Local Institution, Hackensack, New Jersey, United States; Recruiting
Local Institution, New Brunswick, New Jersey, United States; Not yet recruiting
New Mexico
Local Institution, Albuquerque, New Mexico, United States; Not yet recruiting
New York
Local Institution, New York, New York, United States; Not yet recruiting
Local Institution, Buffalo, New York, United States; Not yet recruiting
North Carolina
Local Institution, Chapel Hill, North Carolina, United States; Not yet recruiting
Local Institution, Durham, North Carolina, United States; Not yet recruiting
Ohio
Local Institution, Columbus, Ohio, United States; Not yet recruiting
Oregon
Local Institution, Portland, Oregon, United States; Not yet recruiting
Pennsylvania
Local Institution, Pittsburgh, Pennsylvania, United States; Recruiting
Tennessee
Local Institution, Nashville, Tennessee, United States; Not yet recruiting
Texas
Local Institution, Houston, Texas, United States; Recruiting
Local Institution, Dallas, Texas, United States; Not yet recruiting
Washington
Local Institution, Seattle, Washington, United States; Not yet recruiting
Australia, New South Wales
Local Institution, Sydney, New South Wales, Australia; Recruiting
Australia, Queensland
Local Institution, South Brisbane, Queensland, Australia; Recruiting
Australia, South Australia
Local Institution, Adelaide, South Australia, Australia; Recruiting
Australia, Victoria
Local Institution, East Melbourne, Victoria, Australia; Recruiting
Australia, Western Australia
Local Institution, Perth, Western Australia, Australia; Not yet recruiting
Austria
Local Institution, Wien, Austria; Recruiting
Belgium
Local Institution, B-Leuven, Belgium; Not yet recruiting
Local Institution, Edegem, Belgium; Not yet recruiting
Local Institution, Yvoir, Belgium; Not yet recruiting
Local Institution, BRUXELLES, Belgium; Not yet recruiting
Canada, Alberta
Local Institution, Edmonton, Alberta, Canada; Not yet recruiting
Canada, British Columbia
Local Institution, Vancouver, British Columbia, Canada; Not yet recruiting
Canada, Ontario
Local Institution, Toronto, Ontario, Canada; Not yet recruiting
Canada, Quebec
Local Institution, Montreal, Quebec, Canada; Recruiting
China
Local Institution, Beijing, China; Not yet recruiting
Local Institution, Beijing, China; Not yet recruiting
Local Institution, Shanghai, China; Not yet recruiting
Denmark
Local Institution, Aarhus, Denmark; Not yet recruiting
Finland
Local Institution, Helsinki, Finland; Not yet recruiting
France
Local Institution, Poitiers cedex, France; Recruiting
Local Institution, Pessac, France; Recruiting
Local Institution, Paris Cedex 10, France; Recruiting
Local Institution, Lyon Cedex 03, France; Recruiting
Local Institution, Lille, France; Recruiting
Local Institution, Strasbourg Cedex, France; Recruiting
Local Institution, Nantes, France; Recruiting
Germany
Local Institution, Hamburg, Germany; Recruiting
Local Institution, Mainz, Germany; Recruiting
Local Institution, Mannheim, Germany; Recruiting
Local Institution, Dresden, Germany; Not yet recruiting
Local Institution, Leipzig, Germany; Not yet recruiting
Hungary
Local Institution, Budapest, Hungary; Not yet recruiting
Ireland
Local Institution, Dublin, Ireland; Not yet recruiting
Ireland, Galway
Local Institution, Co Galway, Galway, Ireland; Not yet recruiting
Israel
Local Institution, RAMAT-GAN, Israel; Recruiting
Italy
Local Institution, Bologna, Italy; Recruiting
Local Institution, Roma, Italy; Recruiting
Local Institution, Orbassano, Italy; Not yet recruiting
Local Institution, Milano, Italy; Not yet recruiting
Local Institution, Bari, Italy; Not yet recruiting
Local Institution, Napoli, Italy; Not yet recruiting
Local Institution, Napoli, Italy; Not yet recruiting
Korea, Republic of
Local Institution, Seoul 150-173, Korea, Republic of; Recruiting
Local Institution, Seoul, Korea, Republic of; Not yet recruiting
Local Institution, Seoul, Korea, Republic of; Not yet recruiting
Local Institution, Gwangju, Korea, Republic of; Not yet recruiting
Netherlands
Local Institution, Rotterdam, Netherlands; Not yet recruiting
Local Institution, Nijmegen, Netherlands; Not yet recruiting
Norway
Local Institution, Trondheim, Norway; Not yet recruiting
Philippines
Local Institution, Quezon City, Philippines; Not yet recruiting
Poland
Local Institution, Warsaw, Poland; Not yet recruiting
Local Institution, Lodz, Poland; Not yet recruiting
Local Institution, Szczecin, Poland; Not yet recruiting
Local Institution, Wroclaw, Poland; Not yet recruiting
Local Institution, Lublin, Poland; Not yet recruiting
Local Institution, Gdansk, Poland; Not yet recruiting
Local Institution, Krakow, Poland; Not yet recruiting
Local Institution, Poznan, Poland; Not yet recruiting
Russian Federation
Local Institution, Moscow, Russian Federation; Not yet recruiting
Local Institution, St Petersburg, Russian Federation; Not yet recruiting
Local Institution, Moscow, Russian Federation; Not yet recruiting
Singapore
Local Institution, Singapore, Singapore; Recruiting
South Africa, Free State
Local Institution, Bloemfontein, Free State, South Africa; Not yet recruiting
South Africa, Gauteng
Local Institution, Groenkloof, Gauteng, South Africa; Not yet recruiting
Local Institution, PARKTOWN, Gauteng, South Africa; Not yet recruiting
Local Institution, Johannesburg, Gauteng, South Africa; Not yet recruiting
South Africa, Western Cape
Local Institution, Plumstead, Western Cape, South Africa; Not yet recruiting
Spain
Local Institution, Barcelona, Spain; Not yet recruiting
Local Institution, Madrid, Spain; Not yet recruiting
Local Institution, Madrid, Spain; Not yet recruiting
Sweden
Local Institution, Uppsala, Sweden; Recruiting
Local Institution, Stockholm, Sweden; Not yet recruiting
Local Institution, GOTHENBURG, Sweden; Not yet recruiting
Local Institution, Lund, Sweden; Recruiting
Local Institution, Umea, Sweden; Not yet recruiting
Switzerland
Local Institution, Basel, Switzerland; Recruiting
Taiwan, Province of China
Local Institution, Taipei, Taiwan, Province of China; Recruiting
Local Institution, Taipei, Taiwan, Province of China; Recruiting
Local Institution, Taoyuan, Taiwan, Province of China; Not yet recruiting
United Kingdom, Central
Local Institution, Glasgow, Central, United Kingdom; Recruiting
United Kingdom, Greater London
Local Institution, London, Greater London, United Kingdom; Recruiting
United Kingdom, Tyne and Wear
Local Institution, Newcastle upon Tyne, Tyne and Wear, United Kingdom; Not yet recruiting
More Information
Record last reviewed: March 2005
Last Updated: March 31, 2005
Record first received: January 13, 2005
ClinicalTrials.gov Identifier: NCT00101816
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005
Resources
- Crisis (National Women's Health Information Center)
- Disaster Mental Health: Dealing with the Aftereffects of Terrorism (National Center for Post-Traumatic Stress Disorder)

Not Signed In -


